JP Morgan Lowers PT On Dendreon To $28

August 4, 2011 6:21 AM | 7 seconds read |

JP Morgan has lowered the price target on Dendreon DNDN from $66 to $28 and maintains its Overweight rating.

Posted In: Price Target Analyst Ratings Biotechnology Health Care JP Morgan

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.